Your Questions, Answered

We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.

Filter by topic:

The system will re-enter Initialization Phase for any one of the following reasons:

  • Calibration period has expired without you having entered a fingerstick test value.
  • 3 or more blood glucose readings are significantly different than the current sensor glucose readings.
  • Y our smart transmitter has not been charged within 16 hours of the empty battery alert.
  • If you manually change the time on your mobile device your smart transmitter will sync and reinitialize to your mobile device.
  • A new transmitter has been linked to your existing sensor. For example, if you have replaced your existing transmitter.
  • If you were instructed by Customer Support to re-link your sensor.

SN: Transmitter Serial Number

LBL: Artwork part number

FCC ID:FCC is a US agency that regulates
certain device communications

ques 76.png

To reset the transmitter, follow these steps:

  1. Place the smart transmitter into the charging cradle and connect the USB cable. Plug the cable into the wall outlet. (You can also plug the standard USB end of the cable directly into a USB port on your computer.)
  2. Press and hold the power button (for approx.14 seconds) on the smart transmitter while connected to the USB. Release the power button.
  3. The LED will start blinking in about two seconds indicating the smart transmitter is going through a self-test sequence. The LED will blink in various colors. Once the self-test is complete, the smart transmitter will vibrate and a steady green or orange LED will stay on.
  4. If the self-test does not complete, repeat steps 1 through 3.
  5. If step 3 is successfully completed, the smart transmitter is now ready for use.
  6. Disconnect the smart transmitter from the USB cable and proceed with pairing. Once paired, the system will be in the Initialization Phase.

High Alert – 250 mg/dL

Low Alert – 65 mg/dL

High Target – 180 mg/dL

Low Target - 70 mg/dL

The Smart Transmitter sends glucose data via Bluetooth® to your mobile device running the Eversense® App.

The Eversense® CGM is compatible with Glooko.

Syncing data to Glooko is initiated via the user’s Glooko account. They will need to know their Eversense username and password to link their Eversense account via Glooko.

Still have questions?

The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.

The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.

For important safety information, see bit.ly/eversensesafety

Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.


Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.

 

MKT-001692 Rev 1